4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000196
Director sold 1,727 shares at $23.79 ($41,085)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krognes Steve E. Director | 2024-08-20 | Sale | −1,727 | $23.79 | $41,085 | 32,677 | D: show line 1 in the form |
| Open-market sales · 1,727 sh · avg $23.79 · $41,085 | |||||||
Loading xslF345X05/wk-form4_1724357741.xml…